Bollywood HungamaDisha Patani turns entrepreneur, launches clothing brand DZ with oversized and space-inspired designsPunchArgentine football fan jailed for threatening Di Maria over returnThe Jerusalem PostAI could accelerate quantum computing breakthrough, Bank of America strategist saysInquirerVelasco’s ‘ex-driver’ appears at NBI, alleges he delivered cash suitcases to DuterteZDF heuteAktuelle Pressemitteilungen des ZDFDaily MaverickHOUSEHOLD SQUEEZE: Fuel levy cut offers brief relief as food basket outpaces SA’s unchanged SRD grantХабрПоддержка нескольких реляционных СУБД в одном проекте: PostgreSQL и MSSQLUOLVolkswagen registra prejuízo trimestral de ? 5,8 bilhõesColliderChris Pratt Officially Returns to Streaming in 1 Month With New Military ThrillerThe RegisterMatrix takes sovereign messaging into the realm of the tech giantsWirtualna PolskaProdukowali "kokainę dla ubogich". Grozi im nawet 20 lat więzieniaRMF24W tych polskich gminach żyje się najgorzej. Oto wyniki rankingu
KioskNews
The Daily Newsstand · Free, Always
Thursday, October 29, 2026
Language
Seeking Alpha·United States·

Vanda targets full-year 2026 total revenues greater than $240M as BYSANTI launch nears Q4

Translate

SA Transcript Insights Editor

Earnings Call Insights: Vanda Pharmaceuticals (VNDA) Q3 2026

Management View

  • "We're pleased with the strong revenue growth in the third quarter, increasing 24% year-over-year, driven by continued Fanapt momentum and the early contribution from our NEREUS commercial launch, while operating expenses decreased 18% compared to

Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.